Metric Deep Dive: Understanding China SXT Pharmaceuticals Inc (SXTC) Through its Ratios

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

After finishing at $1.31 in the prior trading day, China SXT Pharmaceuticals Inc (NASDAQ: SXTC) closed at $1.34, up 2.29%. In other words, the price has increased by $2.29 from its previous closing price. On the day, 6.01 million shares were traded.

Ratios:

Our goal is to gain a better understanding of SXTC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.30 and its Current Ratio is at 1.40. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.02.

Valuation Measures:

As of this moment, China’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.17 while its Price-to-Book (P/B) ratio in mrq is 0.04.

Stock Price History:

Over the past 52 weeks, SXTC has reached a high of $11.92, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -31.88%, while the 200-Day Moving Average is calculated to be -62.48%.

Shares Statistics:

Insiders hold about 0.27% of the company’s shares, while institutions hold 0.02% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.